• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

某些C8取代黄嘌呤的腺苷A(2A)拮抗特性。

The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.

作者信息

Van der Walt Mietha M, Terre'Blanche Gisella, Petzer Anél, Lourens Anna C U, Petzer Jacobus P

机构信息

Pharmaceutical Chemistry, School of Pharmacy, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa.

出版信息

Bioorg Chem. 2013 Aug;49:49-58. doi: 10.1016/j.bioorg.2013.06.006. Epub 2013 Jul 4.

DOI:10.1016/j.bioorg.2013.06.006
PMID:23892098
Abstract

The adenosine A2A receptor is considered to be an important target for the development of new therapies for Parkinson's disease. Several antagonists of the A2A receptor have entered clinical trials for this purpose and many research groups have initiated programs to develop A2A receptor antagonists. Most A2A receptor antagonists belong to two different chemical classes, the xanthine derivatives and the amino-substituted heterocyclic compounds. In an attempt to discover high affinity A2A receptor antagonists and to further explore the structure-activity relationships (SARs) of A2A antagonism by the xanthine class of compounds, this study examines the A2A antagonistic properties of series of (E)-8-styrylxanthines, 8-(phenoxymethyl)xanthines and 8-(3-phenylpropyl)xanthines. The results document that among these series, the (E)-8-styrylxanthines have the highest binding affinities with the most potent homologue, (E)-1,3-diethyl-7-methyl-8-[(3-trifluoromethyl)styryl]xanthine, exhibiting a Ki value of 11.9 nM. This compound was also effective in reversing haloperidol-induced catalepsy in rats, providing evidence that it is in fact an A2A receptor antagonist. The importance of substitution at C8 with the styryl moiety was demonstrated by the finding that none of the 8-(phenoxymethyl)xanthines and 8-(3-phenylpropyl)xanthines exhibited high binding affinities for the A2A receptor.

摘要

腺苷A2A受体被认为是开发帕金森病新疗法的重要靶点。为此,几种A2A受体拮抗剂已进入临床试验阶段,许多研究小组也已启动开发A2A受体拮抗剂的项目。大多数A2A受体拮抗剂属于两种不同的化学类别,即黄嘌呤衍生物和氨基取代杂环化合物。为了发现高亲和力的A2A受体拮抗剂,并进一步探索黄嘌呤类化合物对A2A拮抗作用的构效关系(SARs),本研究考察了一系列(E)-8-苯乙烯基黄嘌呤、8-(苯氧甲基)黄嘌呤和8-(3-苯丙基)黄嘌呤的A2A拮抗特性。结果表明,在这些系列中,(E)-8-苯乙烯基黄嘌呤具有最高的结合亲和力,其中最有效的同系物(E)-1,3-二乙基-7-甲基-8-[(3-三氟甲基)苯乙烯基]黄嘌呤的Ki值为11.9 nM。该化合物还能有效逆转氟哌啶醇诱导的大鼠僵住症,证明它实际上是一种A2A受体拮抗剂。8-(苯氧甲基)黄嘌呤和8-(3-苯丙基)黄嘌呤对A2A受体均未表现出高结合亲和力,这一发现证明了C8位被苯乙烯基部分取代的重要性。

相似文献

1
The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.某些C8取代黄嘌呤的腺苷A(2A)拮抗特性。
Bioorg Chem. 2013 Aug;49:49-58. doi: 10.1016/j.bioorg.2013.06.006. Epub 2013 Jul 4.
2
Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A and A receptor antagonists.1,3 - 二乙基 - 7 - 甲基 - 8 -(苯氧甲基)黄嘌呤衍生物作为新型腺苷A和A受体拮抗剂的发现
Bioorg Med Chem Lett. 2016 Dec 15;26(24):5951-5955. doi: 10.1016/j.bmcl.2016.10.086. Epub 2016 Oct 31.
3
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.8-取代的1,3-二甲基四氢吡嗪并[2,1-f]嘌呤二酮:水溶性腺苷受体拮抗剂和单胺氧化酶B抑制剂。
Bioorg Med Chem. 2016 Nov 1;24(21):5462-5480. doi: 10.1016/j.bmc.2016.09.003. Epub 2016 Sep 3.
4
Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.基于稠合黄嘌呤骨架的新型多靶点导向配体,具有芳香取代基,作用于腺苷受体和单胺氧化酶 B。合成、体外和计算机研究。
Bioorg Med Chem. 2019 Apr 1;27(7):1195-1210. doi: 10.1016/j.bmc.2019.02.004. Epub 2019 Feb 2.
5
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.1,3-二烷基取代的四氢嘧啶并[1,2-f]嘌呤-2,4-二酮作为潜在治疗神经退行性疾病的多靶点药物。
Bioorg Med Chem. 2013 Dec 1;21(23):7435-52. doi: 10.1016/j.bmc.2013.09.044. Epub 2013 Sep 25.
6
Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A AR ligands with in vivo efficacy against animal model of Parkinson's disease.1,3,7,8-四取代黄嘌呤类化合物的合成、生物评价及分子模拟研究作为高效和选择性的 A AR 配体,对帕金森病动物模型具有体内疗效。
Bioorg Chem. 2019 Jun;87:601-612. doi: 10.1016/j.bioorg.2019.03.032. Epub 2019 Mar 19.
7
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.新型8-杂环黄嘌呤衍生物作为高效且选择性的人A2B腺苷受体拮抗剂的设计、合成及生物学评价
J Med Chem. 2004 Mar 11;47(6):1434-47. doi: 10.1021/jm0309654.
8
2-Aminopyrimidines as dual adenosine A1/A2A antagonists.2-氨基嘧啶类化合物作为腺苷 A1/A2A 的双重拮抗剂。
Eur J Med Chem. 2015 Nov 2;104:177-88. doi: 10.1016/j.ejmech.2015.09.035. Epub 2015 Oct 3.
9
5-Substituted 2-benzylidene-1-tetralone analogues as A and/or A antagonists for the potential treatment of neurological conditions.5-取代的2-亚苄基-1-四氢萘酮类似物作为A和/或A拮抗剂用于潜在治疗神经疾病。
Bioorg Chem. 2017 Oct;74:251-259. doi: 10.1016/j.bioorg.2017.08.013. Epub 2017 Aug 30.
10
Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC).腺苷A2A受体拮抗剂(E)-8-(3-氯苯乙烯基)咖啡因(CSC)类似物对单胺氧化酶B的抑制作用
Bioorg Med Chem. 2006 May 15;14(10):3512-21. doi: 10.1016/j.bmc.2006.01.011. Epub 2006 Jan 26.

引用本文的文献

1
Unraveling the role of gut microbiota and plasma metabolites in fibromyalgia: Insights from Mendelian randomization and dietary interventions.解析肠道微生物群和血浆代谢物在纤维肌痛中的作用:孟德尔随机化和饮食干预的见解
Mol Pain. 2025 Jan-Dec;21:17448069251332140. doi: 10.1177/17448069251332140. Epub 2025 Mar 21.
2
On the basis of sex: male vs. female rat adenosine A/A receptor affinity.基于性别的差异:雄性与雌性大鼠腺苷 A/A 受体亲和力。
BMC Res Notes. 2023 Aug 10;16(1):165. doi: 10.1186/s13104-023-06346-7.
3
Design, synthesis, anticancer and assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates.
8-咖啡酰基-三唑基甲氧基杂合共轭物的设计、合成、抗癌活性及评估
RSC Adv. 2023 Jan 19;13(5):3056-3070. doi: 10.1039/d2ra07683g. eCollection 2023 Jan 18.
4
Recent Advances in the Synthesis of Xanthines: A Short Review.黄嘌呤合成的最新进展:简短综述
Scientifica (Cairo). 2022 Nov 8;2022:8239931. doi: 10.1155/2022/8239931. eCollection 2022.
5
A Adenosine Receptor Antagonists in Neurodegenerative Diseases.腺嘌呤受体拮抗剂在神经退行性疾病中的应用。
Curr Med Chem. 2022;29(24):4138-4151. doi: 10.2174/0929867328666211129122550.
6
Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.探索腺苷受体配体:在心血管疾病治疗中的潜在作用。
Molecules. 2017 Jun 1;22(6):917. doi: 10.3390/molecules22060917.
7
Lidocaine relaxation in isolated rat aortic rings is enhanced by endothelial removal: possible role of K, K channels and A receptor crosstalk.去除内皮可增强利多卡因对离体大鼠主动脉环的舒张作用:钾、钾通道及A受体相互作用的可能作用
BMC Anesthesiol. 2016 Dec 3;16(1):121. doi: 10.1186/s12871-016-0286-y.
8
Adenosine relaxation in isolated rat aortic rings and possible roles of smooth muscle Kv channels, KATP channels and A2a receptors.腺苷对离体大鼠主动脉环的舒张作用以及平滑肌钾通道、ATP敏感性钾通道和A2a受体的可能作用。
BMC Pharmacol Toxicol. 2016 May 23;17(1):23. doi: 10.1186/s40360-016-0067-8.
9
Selective MAO-B inhibitors: a lesson from natural products.选择性单胺氧化酶-B 抑制剂:源于天然产物的启示。
Mol Divers. 2014 Feb;18(1):219-43. doi: 10.1007/s11030-013-9490-6. Epub 2013 Nov 12.